What's in Agendia's pipeline?

Agendia has 5 drugs in our index: 5 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Agendia's portfolio?

Top competitors by shared drug class: Asan Medical Center, Children's Cancer Group, China, China Breast Cancer Clinical Study Group, European Organisation for Research and Treatment of Cancer - EORTC, Fujian Medical University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/agendia.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

Agendia — Portfolio Competitive Intelligence Brief

Agendia pipeline: 5 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Dose dense AC followed by T + trastuzumab	Dose dense AC followed by T + trastuzumab	marketed	Chemotherapy regimen with monoclonal antibody	HER2 receptor (trastuzumab component); DNA/microtubules (chemotherapy components)	Oncology
TAC chemotherapy	TAC chemotherapy	marketed	Chemotherapy regimen (combination)		Oncology
PTH followed by dose dense AC of FEC	PTH followed by dose dense AC of FEC	marketed	Combination chemotherapy regimen with monoclonal antibody	HER2 receptor; microtubule; DNA (topoisomerase II)	Oncology
TC chemotherapy	TC chemotherapy	marketed	Chemotherapy combination regimen		Oncology
TCH chemotherapy	TCH chemotherapy	marketed	Chemotherapy regimen (combination)	HER2, microtubule, DNA	Oncology

Therapeutic area mix

Oncology · 5

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Asan Medical Center · 1 shared drug class
Children's Cancer Group, China · 1 shared drug class
China Breast Cancer Clinical Study Group · 1 shared drug class
European Organisation for Research and Treatment of Cancer - EORTC · 1 shared drug class
Fujian Medical University · 1 shared drug class
Karolinska University Hospital · 1 shared drug class
MIPO Clinic · 1 shared drug class
AGO Study Group · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Agendia:

Cite this brief

Drug Landscape (2026). Agendia — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/agendia. Accessed 2026-05-13.